Davenport & CO LLC Johnson & Johnson Call Options Transaction History

Davenport & CO LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 24, 2024	BUY	$145.48 - $167.38 $232,767 - $267,808	1,600 Added 17.39%	10,800 $1.75 Million
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $144,380 - $157,780	1,000 Added 12.2%	9,200 $1.34 Million
Q1 2024 May 03, 2024	BUY	$155.22 - $162.74 $605,358 - $634,686	3,900 Added 90.7%	8,200 $1.3 Million
Q4 2023 Jan 23, 2024	BUY	$145.6 - $158.88 $101,920 - $111,216	700 Added 19.44%	4,300 $673,000
Q3 2023 Oct 17, 2023	BUY	$155.75 - $174.48 $280,350 - $314,064	1,800 Added 100.0%	3,600 $560,000
Q2 2023 Jul 20, 2023	BUY	$154.35 - $166.11 $277,830 - $298,998	1,800 New	1,800 $297,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.